The discontinuation literature documents this directly
Of the surveyed physicians, 42% reported that they advise their patients against using compounded GLP-1s for weight loss
Dunger DB, Bruggraber SFA, Mander AP et al (2022) INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes
Benefits include: Enhanced tissue repair (muscles, tendons, ligaments) Reduced inflammation and joint discomfort Faster recovery from workouts or injuries This makes it a key player in injury recovery, inflammation reduction, and performance optimization
Ozempic is approved for managing type 2 diabetes
Atlantic provinces show higher obesity rates than the national average